We were unable to update this podcast for some time now. As a result, the information shown here might be outdated. If you are the owner of the podcast, you can validate that your RSS feed is available and correct.
It looks like this podcast has ended some time ago. This means that no new episodes have been added some time ago. If you're the host of this podcast, you can check whether your RSS file is reachable for podcast clients.
StockMarketFunding
by ArchiveStockMarketFunding.com will provide commentary on the economy, your investments, the current economic outlook for 2010, options trading strategies, international investing, communities, currencies, technical analysis, and more!
Copyright: Copyright Archive
Episodes
2012 Global Economic Recession & Banking Crisis
29m · PublishedStocks Surge 3% After Central Bank Action; Dow Up More Than 400. In this live talk radio show we'll cover the 2012 Global Economic Recession possibilities, the recent Banking Crisis, if it's time to invest in gold, and what's next for Apple Computers (AAPL). Financial Banking Crisis 2011 S&P Downgrade Spree, Hits 37 U.S. Banks! In this live stock market education radio show will cover all the recent banking sector moves after hours as markets have just been dealt a dose of global bank downgrades by S&P. Global stress on the financial markets means forced liquidation, margin debt selling this is the main reason why we saw NASDAQ and technology related stock selloff the hardest today. Will Germany save Europe? S&P Downgrades Goldman Sachs, Bank Of America, Wells Fargo, and Citigroup to an "A-" minus rating, down from an "A" rating. Bank of America N.A. (BAC) to A from A+Bank of New York Mellon Corp. (BK) to A+ from AA-Barclays PLC (BCS) to A from A+Citibank N.A. (C) to A from A+Goldman Sachs & Co. (GS) to A from A+JPMorgan Chase & Co. (JPM) to A from A+Morgan Stanley (MS) to A- from AWells Fargo Bank N.A. (WFC) to AA- from AA
Stock Market Index Analysis and Market Commentary & Market Experiences
44m · PublishedStock Market Index Analysis and Market Commentary
1m · PublishedHuman Genome Sciences Lupus Drug FDA Program Schedule Assuming the Worst Market Manipulation?
51m · PublishedBENLYSTA has successfully met its primary endpoint in two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). In June 2010, HGS and GSK submitted regulatory applications seeking approval to market BENLYSTA in the United States and Europe. The FDA has granted BENLYSTA a priority review designation with a Prescription Drug User Fee Act (PDUFA) target date of December 9, 2010 – so it is possible that BENLYSTA could receive regulatory approval in the United States before the end of 2010.
Human Genome Sciences Benlysta Drug Approval for Lupus Patients
58m · PublishedBENLYSTA has successfully met its primary endpoint in two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). In June 2010, HGS and GSK submitted regulatory applications seeking approval to market BENLYSTA in the United States and Europe. The FDA has granted BENLYSTA a priority review designation with a Prescription Drug User Fee Act (PDUFA) target date of December 9, 2010 – so it is possible that BENLYSTA could receive regulatory approval in the United States before the end of 2010.
StockMarketFunding has 5 episodes in total of non- explicit content. Total playtime is 3:06:18. The language of the podcast is English. This podcast has been added on October 28th 2022. It might contain more episodes than the ones shown here. It was last updated on February 15th, 2023 04:20.